| 1 | Fragile X Syndrome | 24.1% |
| 2 | Familial Mediterranean Fever | 22% |
| 3 | Multiple Epiphyseal Dysplasia | 21.8% |
| 4 | Osteochondrodysplasias | 21.8% |
| 5 | Pelger-Huet Anomaly | 21.8% |
| 6 | Werner Syndrome | 21.8% |
| 7 | Myasthenic Syndromes, Congenital | 21.8% |
| 8 | CHARGE Syndrome | 21.4% |
| 9 | Aicardi's syndrome | 21.4% |
| 10 | Beckwith-Wiedemann Syndrome | 21.1% |
| 11 | Wolf-Hirschhorn Syndrome | 21.1% |
| 12 | Hamartoma | 21.1% |
| 13 | Neoplasms, Hormone-Dependent | 21.1% |
| 14 | Neoplasms, Multiple Primary | 21.1% |
| 15 | Paraneoplastic Syndromes | 21.1% |
| 16 | Precancerous Conditions | 21.1% |
| 17 | Neoplasms, Second Primary | 21.1% |
| 18 | Anemia, Sickle Cell | 20.7% |
| 19 | Thalassemia | 20.7% |
| 20 | Carcinoma 256, Walker | 20.7% |
| 21 | Medulloblastoma | 20.7% |
| 22 | Muscular Dystrophy, Duchenne | 20.6% |
| 23 | Rett Syndrome | 20.6% |
| 24 | Cystic Fibrosis | 19.5% |
| 25 | Neoplasms, Neuroepithelial | 19.4% |
| 26 | Gliomatosis cerebri | 19.4% |
| 27 | Albinism | 19.4% |
| 28 | Ichthyosis, X-Linked | 19% |
| 29 | Carcinoma, Ehrlich Tumor | 18.9% |
| 30 | Dermoid Cyst | 18.9% |
| 31 | Carcinoma, Lewis Lung | 18.9% |
| 32 | Mucopolysaccharidosis II | 18.8% |
| 33 | melanoma | 18.6% |
| 34 | Melanoma, Experimental | 18.2% |
| 35 | Cockayne Syndrome | 18% |
| 36 | Dwarfism | 17.9% |
| 37 | Nail-Patella Syndrome | 17.9% |
| 38 | Neuroectodermal Tumors | 17.9% |
| 39 | Adenoma, Acidophil | 17.8% |
| 40 | Ganglioneuroma | 17.8% |
| 41 | Glioma | 17.8% |
| 42 | Malignant Glioma | 17.8% |
| 43 | Alstrom Syndrome | 17.7% |
| 44 | Smith-Magenis syndrome | 17.6% |
| 45 | Carcinoid Tumor | 17.4% |
| 46 | Neurilemmoma | 17.4% |
| 47 | Hutchinson's Melanotic Freckle | 17.4% |
| 48 | Melanoma, Amelanotic | 17.4% |
| 49 | Cri-du-Chat Syndrome | 17.3% |
| 50 | Down Syndrome | 17.3% |
| 51 | Trisomy 21 | 17.3% |
| 52 | Muscular Dystrophy | 17% |
| 53 | Osteogenesis Imperfecta | 17% |
| 54 | Astrocytoma | 17% |
| 55 | Ependymoma | 17% |
| 56 | oligodendroglioma | 17% |
| 57 | Ganglioglioma | 17% |
| 58 | gliosarcoma | 17% |
| 59 | Anaplastic astrocytoma | 17% |
| 60 | Anaplastic Oligodendroglioma | 17% |
| 61 | Sickle Cell Trait | 17% |
| 62 | Carcinosarcoma | 16.8% |
| 63 | Hemangiosarcoma | 16.8% |
| 64 | Leukemia L1210 | 16.8% |
| 65 | Leukemia P388 | 16.8% |
| 66 | lymphangiosarcoma | 16.8% |
| 67 | Acanthoma | 16.8% |
| 68 | Malignant Carcinoid Syndrome | 16.8% |
| 69 | Glioblastoma | 16.6% |
| 70 | Neuroblastoma | 16.6% |
| 71 | Glioblastoma Multiforme | 16.6% |
| 72 | Menkes Kinky Hair Syndrome | 16.6% |
| 73 | Ganglioneuroblastoma | 16.4% |
| 74 | Meningioma | 16.3% |
| 75 | Sarcoma 180 | 16.3% |
| 76 | Amino Acid Metabolism, Inborn Errors | 16.1% |
| 77 | Carbohydrate Metabolism, Inborn Errors | 16.1% |
| 78 | Metal Metabolism, Inborn Errors | 16.1% |
| 79 | Progeria | 16.1% |
| 80 | Lysosomal Storage Diseases | 16.1% |
| 81 | Cytochrome-c Oxidase Deficiency | 16.1% |
| 82 | Peroxisomal Disorders | 16.1% |
| 83 | Paraneoplastic Encephalomyelitis | 15.9% |
| 84 | Basal cell carcinoma | 15.8% |
| 85 | Carcinoma, Papillary | 15.8% |
| 86 | Squamous cell carcinoma | 15.8% |
| 87 | Chondrosarcoma | 15.8% |
| 88 | Craniopharyngioma | 15.8% |
| 89 | Cystadenoma | 15.8% |
| 90 | leiomyosarcoma | 15.8% |
| 91 | liposarcoma | 15.8% |
| 92 | Mesothelioma | 15.8% |
| 93 | synovial sarcoma | 15.8% |
| 94 | Neuroectodermal Tumor, Melanotic | 15.8% |
| 95 | Angiomyolipoma | 15.8% |
| 96 | Clear Cell Sarcoma of Soft Tissue | 15.8% |
| 97 | Alveolar Soft Part Sarcoma | 15.8% |
| 98 | Neuroendocrine Tumors | 15.8% |
| 99 | Deformity | 15.8% |
| 100 | Sarcoma, Myeloid | 15.8% |
| 101 | Carcinoma, Basal Cell | 15.8% |
| 102 | Trophoblastic Neoplasms | 15.7% |
| 103 | Choriocarcinoma | 15.7% |
| 104 | Carcinoma, Lobular | 15.7% |
| 105 | Leukemia, Experimental | 15.6% |
| 106 | Mammary Neoplasms, Experimental | 15.6% |
| 107 | Cyst | 15.4% |
| 108 | Neoplastic Processes | 15.4% |
| 109 | Pregnancy Complications, Neoplastic | 15.4% |
| 110 | Wiskott-Aldrich Syndrome | 15.4% |
| 111 | Neuronal Ceroid-Lipofuscinoses | 15.3% |
| 112 | Cystadenocarcinoma | 15.3% |
| 113 | Fibrosarcoma | 15.3% |
| 114 | Osteosarcoma | 15.3% |
| 115 | Mucoepidermoid Carcinoma | 15.3% |
| 116 | Smith-Lemli-Opitz Syndrome | 15.2% |
| 117 | Holoprosencephaly | 15.2% |
| 118 | Neoplasms, Experimental | 15.1% |
| 119 | Adenofibroma | 15% |
| 120 | Fibroadenoma | 15% |
| 121 | Malignant Fibrous Histiocytoma | 15% |
| 122 | Abdominal Neoplasms | 15% |
| 123 | Erythroplasia | 15% |
| 124 | Follicular cyst | 15% |
| 125 | Head and Neck Neoplasms | 15% |
| 126 | leukemia | 15% |
| 127 | Mucocele | 15% |
| 128 | Neoplasms, Germ Cell and Embryonal | 15% |
| 129 | Neoplasms, Glandular and Epithelial | 15% |
| 130 | Pilonidal Cyst | 15% |
| 131 | Soft Tissue Neoplasms | 15% |
| 132 | Thoracic Neoplasms | 15% |
| 133 | Thyroglossal Cyst | 15% |
| 134 | Synovial Cyst | 15% |
| 135 | Germ Cell Cancer | 15% |
| 136 | Aberrant Crypt Foci | 15% |
| 137 | Ectodermal Dysplasia | 14.9% |
| 138 | Aplasia Cutis Congenita | 14.9% |
| 139 | Sarcoma, Experimental | 14.8% |
| 140 | Bowen's Disease | 14.8% |
| 141 | Paraganglioma | 14.8% |
| 142 | Rhabdomyosarcoma | 14.8% |
| 143 | Giant Cell Tumor of Bone | 14.8% |
| 144 | Prader-Willi Syndrome | 14.7% |
| 145 | Tuberous Sclerosis | 14.7% |
| 146 | Dermatofibrosarcoma | 14.5% |
| 147 | Dermatofibrosarcoma Protuberans | 14.5% |
| 148 | Kartagener Syndrome | 14.4% |
| 149 | Pheochromocytoma | 14.3% |
| 150 | Alveolar rhabdomyosarcoma | 14.3% |
| 151 | Autoimmune Lymphoproliferative Syndrome | 14.3% |
| 152 | Primary Ciliary Dyskinesia | 14.3% |
| 153 | Carcinoid Heart Disease | 13.9% |
| 154 | Angioedemas, Hereditary | 13.9% |
| 155 | Polycystic Kidney Diseases | 13.8% |
| 156 | Williams Syndrome | 13.8% |
| 157 | Myotonic Dystrophy | 13.6% |
| 158 | Marfan Syndrome | 13.5% |
| 159 | Adrenoleukodystrophy | 13.4% |
| 160 | Glycogen storage disease type II | 13.3% |
| 161 | Thymoma | 13.3% |
| 162 | Retinoblastoma | 13.2% |
| 163 | Rubinstein-Taybi Syndrome | 13.2% |
| 164 | Leukemia, Plasma Cell | 13.2% |
| 165 | Alkaptonuria | 13.2% |
| 166 | Glycogen Storage Disease | 13.2% |
| 167 | Hypophosphatasia | 13.2% |
| 168 | Propionic acidemia | 13.2% |
| 169 | Dihydropyrimidine Dehydrogenase Deficiency | 13.2% |
| 170 | Cystinosis | 13.2% |
| 171 | Fabry Disease | 13.1% |
| 172 | Leukemia, Radiation-Induced | 13% |
| 173 | Carcinoma, Pancreatic Ductal | 13% |
| 174 | Mucopolysaccharidosis III | 12.9% |
| 175 | Sjogren-Larsson Syndrome | 12.9% |
| 176 | Acute Chest Syndrome | 12.9% |
| 177 | Cutis Laxa | 12.9% |
| 178 | Acoustic Neuroma | 12.9% |
| 179 | Retinitis Pigmentosa | 12.8% |
| 180 | Pigmentary retinopathy | 12.8% |
| 181 | Refsum Disease | 12.7% |
| 182 | Porokeratosis | 12.7% |
| 183 | Keratoderma, Palmoplantar | 12.7% |
| 184 | Chronic granulomatous disease | 12.6% |
| 185 | Galactosemias | 12.6% |
| 186 | Urea Cycle Disorders, Inborn | 12.6% |
| 187 | Tyrosinemias | 12.6% |
| 188 | Welander Distal Myopathy | 12.5% |
| 189 | Xeroderma Pigmentosum | 12.4% |
| 190 | Hepatolenticular Degeneration | 12.4% |
| 191 | Vipoma | 12.3% |
| 192 | Amyloid Neuropathies, Familial | 12.3% |
| 193 | Retinal Dysplasia | 12.2% |
| 194 | Adenoma | 12.2% |
| 195 | Ameloblastoma | 12.2% |
| 196 | Angiokeratoma | 12.2% |
| 197 | Carcinoma | 12.2% |
| 198 | Chordoma | 12.2% |
| 199 | Hemangioma | 12.2% |
| 200 | hemangiopericytoma | 12.2% |
| 201 | Lymphangioma | 12.2% |
| 202 | Mesenchymoma | 12.2% |
| 203 | Nevus | 12.2% |
| 204 | Retroperitoneal Neoplasms | 12.2% |
| 205 | Teratoma | 12.2% |
| 206 | Hepatoblastoma | 12.2% |
| 207 | Mixed Tumor, Mullerian | 12.2% |
| 208 | Germinoma | 12.2% |
| 209 | Teratocarcinoma | 12.2% |
| 210 | Angiofibroma | 12.2% |
| 211 | Sarcoma | 12.2% |
| 212 | Epithelioma | 12.2% |
| 213 | Kallmann Syndrome | 12.1% |
| 214 | Aniridia | 12.1% |
| 215 | Neurofibrosarcoma | 12% |
| 216 | Hydatidiform Mole | 12% |
| 217 | Parathyroid Neoplasms | 11.9% |
| 218 | Peritoneal Neoplasms | 11.9% |
| 219 | Thyroid Neoplasm | 11.9% |
| 220 | Thyroid carcinoma | 11.9% |
| 221 | Epidermolysis Bullosa | 11.9% |
| 222 | Neoplasms, Radiation-Induced | 11.9% |
| 223 | Glycogen Storage Disease Type I | 11.7% |
| 224 | Glycogen Storage Disease Type V | 11.7% |
| 225 | Lymphomatoid Granulomatosis | 11.7% |
| 226 | Digestive System Neoplasms | 11.5% |
| 227 | Endocrine Gland Neoplasms | 11.5% |
| 228 | Eye Neoplasms | 11.5% |
| 229 | Fetal Diseases | 11.5% |
| 230 | Nervous System Neoplasms | 11.5% |
| 231 | Composite Lymphoma | 11.5% |
| 232 | Optic Nerve Glioma | 11.4% |
| 233 | Classical Lissencephalies and Subcortical Band Heterotopias | 11.4% |
| 234 | Gaucher Disease | 11.3% |
| 235 | Polycystic Kidney, Autosomal Dominant | 11.3% |
| 236 | Tracheal Neoplasms | 11.2% |
| 237 | Multiple Endocrine Neoplasia | 11.2% |
| 238 | Optic Atrophy, Hereditary, Leber | 11.2% |
| 239 | Hyperphosphaturia | 11.1% |
| 240 | Bone neoplasms | 11.1% |
| 241 | Leukoplakia | 11.1% |
| 242 | Lymphocele | 11.1% |
| 243 | Pancreatic Cyst | 11.1% |
| 244 | Skin Neoplasms | 11.1% |
| 245 | Hematologic Neoplasms | 11.1% |
| 246 | Leukoplakia, Oral | 11% |
| 247 | Paraneoplastic Cerebellar Degeneration | 10.9% |
| 248 | Barrett Esophagus | 10.9% |
| 249 | Breast Cyst | 10.9% |
| 250 | Histiocytic Disorders, Malignant | 10.9% |
| 251 | Actinic keratosis | 10.9% |
| 252 | Mediastinal Cyst | 10.9% |
| 253 | Neoplasm Invasiveness | 10.9% |
| 254 | Neoplasm Metastasis | 10.9% |
| 255 | Neoplasm Recurrence, Local | 10.9% |
| 256 | Parovarian Cyst | 10.9% |
| 257 | Pericardial Cyst | 10.9% |
| 258 | Splenic Neoplasms | 10.9% |
| 259 | Thymic Cyst | 10.9% |
| 260 | Carcinogenesis | 10.9% |
| 261 | Myxoid cyst | 10.9% |
| 262 | Metastasis | 10.9% |
| 263 | Adenocarcinoma | 10.8% |
| 264 | Carcinoma in Situ | 10.8% |
| 265 | Carcinoma, Transitional Cell | 10.8% |
| 266 | Phyllodes Tumor | 10.8% |
| 267 | Dysgerminoma | 10.8% |
| 268 | Hemangioendothelioma | 10.8% |
| 269 | Lipoma | 10.8% |
| 270 | Myoma | 10.8% |
| 271 | Myxoma | 10.8% |
| 272 | Neuroma | 10.8% |
| 273 | Papilloma | 10.8% |
| 274 | Pseudomyxoma Peritonei | 10.8% |
| 275 | Seminoma | 10.8% |
| 276 | Papillomatosis | 10.8% |
| 277 | Angiolipoma | 10.8% |
| 278 | Myelolipoma | 10.8% |
| 279 | Neoplasms, Bone Tissue | 10.8% |
| 280 | Neoplasms, Fibrous Tissue | 10.8% |
| 281 | Smooth Muscle Tumor | 10.8% |
| 282 | Adenomatosis, Pulmonary | 10.8% |
| 283 | Adenomatous Polyps | 10.8% |
| 284 | Carcinoma, Large Cell | 10.8% |
| 285 | Carcinoma, Small Cell | 10.8% |
| 286 | Desmoplastic Small Round Cell Tumor | 10.8% |
| 287 | Chondroma | 10.8% |
| 288 | Enchondroma | 10.8% |
| 289 | Tay-Sachs Disease | 10.8% |
| 290 | Choledochal Cyst | 10.7% |
| 291 | Duane Retraction Syndrome | 10.7% |
| 292 | Homocystinuria | 10.7% |
| 293 | insulinoma | 10.6% |
| 294 | Porphyrias, Hepatic | 10.6% |
| 295 | Leigh Disease | 10.6% |
| 296 | Gastrinoma | 10.5% |
| 297 | Glucagonoma | 10.5% |
| 298 | Canavan Disease | 10.5% |
| 299 | Alexander Disease | 10.5% |
| 300 | Endometrial Stromal Sarcoma | 10.4% |
| 301 | Myotonia Congenita | 10.4% |
| 302 | Thrombasthenia | 10.4% |
| 303 | Antithrombin III Deficiency | 10.4% |
| 304 | Protein C Deficiency | 10.4% |
| 305 | Brain Diseases, Metabolic, Inborn | 10.4% |
| 306 | Liver Neoplasms, Experimental | 10.4% |
| 307 | Afibrinogenemia | 10.3% |
| 308 | Dystonia Musculorum Deformans | 10.3% |
| 309 | Factor VII Deficiency | 10.3% |
| 310 | Factor X Deficiency | 10.3% |
| 311 | Factor XII Deficiency | 10.3% |
| 312 | Hemophilia A | 10.3% |
| 313 | Hypolipoproteinemias | 10.3% |
| 314 | Papillon-Lefevre Disease | 10.3% |
| 315 | Thyroid Nodule | 10.3% |
| 316 | Hepatocellular Adenoma | 10.3% |
| 317 | Activated Protein C Resistance | 10.3% |
| 318 | Factor II deficiency | 10.3% |
| 319 | Factor VIII Deficiency | 10.3% |
| 320 | Factor V deficiency | 10.3% |
| 321 | Factor XI Deficiency | 10.3% |
| 322 | Hypoprothrombinemias | 10.3% |
| 323 | Hyperlipidemia, Familial Combined | 10.3% |
| 324 | Hyperlipoproteinemia Type III | 10.3% |
| 325 | Fanconi Anemia | 10.3% |
| 326 | Lafora Disease | 10.2% |
| 327 | Unverricht-Lundborg Syndrome | 10.2% |
| 328 | Hyperkeratosis, Epidermolytic | 10.2% |
| 329 | Lymphangioleiomyomatosis | 10.2% |
| 330 | Anemia, Diamond-Blackfan | 10.2% |
| 331 | Pancreatic Neoplasm | 10.2% |
| 332 | Adenoid Cystic Carcinoma | 10.2% |
| 333 | fibroma | 10.2% |
| 334 | Fibromatosis | 10.2% |
| 335 | Osteoblastoma | 10.2% |
| 336 | Osteoma | 10.2% |
| 337 | Rhabdomyoma | 10.2% |
| 338 | Chondromatosis | 10.2% |
| 339 | Adenocarcinoma, Clear Cell | 10.2% |
| 340 | Cholangiocarcinoma | 10.2% |
| 341 | Cervical Intraepithelial Neoplasia | 10.2% |
| 342 | Hemangioblastoma | 10.2% |
| 343 | Lymphoma, Extranodal NK-T-Cell | 10.2% |
| 344 | Zellweger Syndrome | 10.1% |
| 345 | Niemann-Pick Disease, Type C | 10% |
| 346 | Abdominal Cramps | 10% |
| 347 | Abnormalities, Drug-Induced | 10% |
| 348 | Amniotic Band Syndrome | 10% |
| 349 | Asphyxia Neonatorum | 10% |
| 350 | Infant, Premature, Diseases | 10% |
| 351 | Situs Inversus | 10% |
| 352 | Infantile Colic | 10% |
| 353 | Carbamoyl-Phosphate Synthase I Deficiency Disease | 10% |
| 354 | Fibromatosis, Aggressive | 9.9% |
| 355 | Fibromatosis, Abdominal | 9.9% |
| 356 | Klatskin Tumor | 9.9% |
| 357 | Charcot-Marie-Tooth Disease | 9.7% |
| 358 | Antley-Bixler Syndrome Phenotype | 9.7% |
| 359 | Basal Cell Nevus Syndrome | 9.6% |
| 360 | Esophageal Neoplasms | 9.4% |
| 361 | Multiple Endocrine Neoplasia Type 1 | 9.3% |
| 362 | Leydig Cell Tumor | 9.3% |
| 363 | Limbic Encephalitis | 9.3% |
| 364 | Ataxia Telangiectasia | 9.2% |
| 365 | Hypoalphalipoproteinemias | 9.2% |
| 366 | Pseudoxanthoma Elasticum | 9.2% |
| 367 | Mouth Neoplasms | 9.1% |
| 368 | Central Nervous System Neoplasms | 9.1% |
| 369 | Vascular Neoplasms | 9.1% |
| 370 | Thymus Neoplasms | 9.1% |
| 371 | Congenital Hypothyroidism | 9% |
| 372 | Genital Neoplasms, Female | 8.9% |
| 373 | Pancreatic Pseudocyst | 8.9% |
| 374 | Plasmacytoma | 8.9% |
| 375 | Dermatitis, Atopic | 8.9% |
| 376 | Malignant histiocytosis | 8.8% |
| 377 | Lymphatic Metastasis | 8.8% |
| 378 | Neoplasms, Unknown Primary | 8.8% |
| 379 | Leukemic Infiltration | 8.8% |
| 380 | Breast Neoplasms, Male | 8.8% |
| 381 | Histiocytic sarcoma | 8.8% |
| 382 | Neoplasm Micrometastasis | 8.8% |
| 383 | Triple Negative Breast Neoplasms | 8.8% |
| 384 | Central Nervous System Cysts | 8.8% |
| 385 | Prolactinoma | 8.7% |
| 386 | Growth Hormone-Secreting Pituitary Adenoma | 8.7% |
| 387 | Familial Periodic Paralysis | 8.7% |
| 388 | Lactose Intolerance | 8.6% |
| 389 | Lymphoma | 8.6% |
| 390 | Variegate Porphyria | 8.6% |
| 391 | Acute intermittent porphyria | 8.6% |
| 392 | Porphyria Cutanea Tarda | 8.6% |
| 393 | Hyperhomocysteinemia | 8.5% |
| 394 | Renal Aminoacidurias | 8.5% |
| 395 | Fanconi Syndrome | 8.5% |
| 396 | Pseudohypoaldosteronism | 8.5% |
| 397 | Liddle Syndrome | 8.5% |
| 398 | Corpus Luteum Cyst | 8.5% |
| 399 | Ovarian Cysts | 8.5% |
| 400 | Hyperlipoproteinemia Type IV | 8.5% |
| 401 | Hyperlipoproteinemia Type V | 8.5% |
| 402 | Klinefelter Syndrome | 8.3% |
| 403 | Xeroderma | 8.2% |
| 404 | Mobius Syndrome | 8.2% |
| 405 | Lambert-Eaton Myasthenic Syndrome | 8.2% |
| 406 | Testicular Neoplasms | 8.2% |
| 407 | Adrenocortical carcinoma | 8.2% |
| 408 | Meconium Aspiration Syndrome | 8.2% |
| 409 | Meningeal Neoplasms | 8% |
| 410 | Leukemia, Myelomonocytic, Chronic | 7.9% |
| 411 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.9% |
| 412 | Mesoblastic Nephroma | 7.8% |
| 413 | Behcet Syndrome | 7.7% |
| 414 | Anencephaly | 7.7% |
| 415 | Eye Abnormalities | 7.7% |
| 416 | Cardiovascular Abnormalities | 7.7% |
| 417 | Hypokalemic periodic paralysis | 7.7% |
| 418 | Cystinuria | 7.6% |
| 419 | granulosa cell tumor | 7.6% |
| 420 | Carcinoma, Ovarian Epithelial | 7.6% |
| 421 | Mastocytoma | 7.5% |
| 422 | Gout | 7.4% |
| 423 | Meningeal Carcinomatosis | 7.4% |
| 424 | Mastocytosis, Systemic | 7.4% |
| 425 | Palatal Neoplasms | 7.4% |
| 426 | Skin Abnormalities | 7.4% |
| 427 | Lymphatic Abnormalities | 7.4% |
| 428 | Congenital Microtia | 7.4% |
| 429 | Leukemia, Myeloid, Chronic-Phase | 7.4% |
| 430 | Hydrops Fetalis | 7.4% |
| 431 | Pseudohypoparathyroidism | 7.4% |
| 432 | Prune Belly Syndrome | 7.3% |
| 433 | Twins, Conjoined | 7.3% |
| 434 | Waardenburg Syndrome | 7.3% |
| 435 | Anemia, Neonatal | 7.3% |
| 436 | Persistent Fetal Circulation Syndrome | 7.3% |
| 437 | Friedreich Ataxia | 7.3% |
| 438 | Opsoclonus-Myoclonus Syndrome | 7.3% |
| 439 | Adrenal Gland Neoplasms | 7.2% |
| 440 | Gastrointestinal Neoplasms | 7.2% |
| 441 | Genital Neoplasms, Male | 7.2% |
| 442 | Liver neoplasms | 7.2% |
| 443 | Uveal Neoplasms | 7.2% |
| 444 | Renal tubular acidosis | 7.2% |
| 445 | Congenital diaphragmatic hernia | 7.2% |
| 446 | Umbilical hernia | 7.2% |
| 447 | Urologic Neoplasms | 7.1% |
| 448 | Renal Cell Carcinoma | 7.1% |
| 449 | Papillary Renal Cell Carcinoma | 7.1% |
| 450 | Sebaceous Gland Neoplasms | 7% |
| 451 | Spinal Neoplasms | 7% |
| 452 | Bone Marrow Neoplasms | 7% |
| 453 | Turner Syndrome | 7% |
| 454 | Nose Neoplasms | 7% |
| 455 | Hodgkin Disease | 6.9% |
| 456 | Lymphoma, Non-Hodgkin | 6.9% |
| 457 | Carcinoma, Endometrioid | 6.9% |
| 458 | Polycystic Ovary Syndrome | 6.9% |
| 459 | Huntington Disease | 6.8% |
| 460 | Arthritis, Gouty | 6.5% |
| 461 | Ear Neoplasms | 6.5% |
| 462 | Eyelid Neoplasms | 6.5% |
| 463 | Lung Neoplasms | 6.5% |
| 464 | Pleural Neoplasms | 6.5% |
| 465 | Maxillofacial Abnormalities | 6.4% |
| 466 | Dural Arteriovenous Fistula | 6.4% |
| 467 | Myelitis, Transverse | 6.4% |
| 468 | Nasopharyngeal carcinoma | 6.4% |
| 469 | Mastocytosis | 6.4% |
| 470 | Sturge-Weber Syndrome | 6.4% |
| 471 | Dextrocardia | 6.4% |
| 472 | Cell Transformation, Viral | 6.3% |
| 473 | Brain Neoplasms | 6.3% |
| 474 | Salivary Gland Neoplasms | 6.3% |
| 475 | Spinal Cord Neoplasms | 6.3% |
| 476 | Tongue Neoplasms | 6.3% |
| 477 | Gastrointestinal Stromal Tumors | 6.3% |
| 478 | Familial Hypophosphatemic Rickets | 6.3% |
| 479 | Hemangioma, Cavernous | 6.2% |
| 480 | Nephroblastoma | 6.2% |
| 481 | Leukemia, T-Cell | 6.2% |
| 482 | Uterine Neoplasms | 6.2% |
| 483 | Vaginal Neoplasms | 6.2% |
| 484 | Vulvar Neoplasms | 6.2% |
| 485 | Uterine Cancer | 6.2% |
| 486 | Leukemia, B-Cell | 6.2% |
| 487 | Fallopian Tube Neoplasms | 6.2% |
| 488 | neurofibroma | 6.2% |
| 489 | Lymphoma, Follicular | 6.2% |
| 490 | T-Cell Lymphoma | 6.2% |
| 491 | Mantle cell lymphoma | 6.2% |
| 492 | Pituitary Adenoma | 6.1% |
| 493 | Pituitary Neoplasms | 6.1% |
| 494 | Urogenital Abnormalities | 6.1% |
| 495 | Bronchial Neoplasms | 6% |
| 496 | Multiple Pulmonary Nodules | 5.9% |
| 497 | Neonatal Abstinence Syndrome | 5.9% |
| 498 | Supratentorial Neoplasms | 5.8% |
| 499 | Dupuytren Contracture | 5.8% |
| 500 | Endometrial Neoplasms | 5.8% |
| 501 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 502 | Leukemia, Large Granular Lymphocytic | 5.8% |
| 503 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 504 | Lymphoma, T-Cell, Cutaneous | 5.8% |
| 505 | Lymphoma, AIDS-Related | 5.8% |
| 506 | Enteropathy-Associated T-Cell Lymphoma | 5.8% |
| 507 | Primary Effusion Lymphoma | 5.8% |
| 508 | Primary amyloidosis | 5.8% |
| 509 | Fetal Growth Retardation | 5.7% |
| 510 | Urticaria Pigmentosa | 5.7% |
| 511 | Fetal Hypoxia | 5.7% |
| 512 | Congenital nystagmus | 5.7% |
| 513 | Fetal Alcohol Spectrum Disorders | 5.7% |
| 514 | Brain Stem Neoplasms | 5.6% |
| 515 | Toxoplasmosis, Congenital | 5.6% |
| 516 | Syphilis, Congenital | 5.6% |
| 517 | Mycosis Fungoides | 5.6% |
| 518 | Lymphomatoid Papulosis | 5.6% |
| 519 | Plasmablastic lymphoma | 5.6% |
| 520 | Glycosuria, Renal | 5.6% |
| 521 | Choroid Plexus Papilloma | 5.5% |
| 522 | Anophthalmos | 5.5% |
| 523 | Anus, Imperforate | 5.5% |
| 524 | Hydranencephaly | 5.5% |
| 525 | Microphthalmos | 5.5% |
| 526 | Neural Tube Defects | 5.5% |
| 527 | Paralysis, Obstetric | 5.5% |
| 528 | Retinopathy of Prematurity | 5.5% |
| 529 | Tethered Cord Syndrome | 5.5% |
| 530 | Iniencephaly | 5.5% |
| 531 | Craniorachischisis | 5.5% |
| 532 | Limb Deformities, Congenital | 5.5% |
| 533 | Exencephaly | 5.5% |
| 534 | Septo-Optic Dysplasia | 5.5% |
| 535 | Craniofacial Abnormalities | 5.5% |
| 536 | Cortical Dysplasia | 5.5% |
| 537 | Malformations of Cortical Development | 5.5% |
| 538 | Anorectal Malformations | 5.5% |
| 539 | Microcephaly | 5.4% |
| 540 | Macrocephaly | 5.4% |
| 541 | Pharyngeal Neoplasms | 5.4% |
| 542 | Bloom Syndrome | 5.4% |
| 543 | Bronchopulmonary Dysplasia | 5.3% |
| 544 | Bile Duct Neoplasms | 5.2% |
| 545 | gallbladder neoplasm | 5.2% |
| 546 | Intestinal Neoplasms | 5.2% |
| 547 | Penile Neoplasms | 5.2% |
| 548 | Prostatic Neoplasms | 5.2% |
| 549 | Stomach Neoplasms | 5.2% |
| 550 | Polycythemia Vera | 5.1% |
| 551 | Denys-Drash Syndrome | 5.1% |
| 552 | Porencephaly | 5.1% |
| 553 | Adenomatous Polyposis Coli | 5.1% |
| 554 | ovarian neoplasm | 4.9% |
| 555 | Acrocephalosyndactylia | 4.9% |
| 556 | Hypopharyngeal Neoplasms | 4.9% |
| 557 | Pleural Effusion, Malignant | 4.9% |
| 558 | Hypopharyngeal Cancer | 4.9% |
| 559 | Craniosynostosis | 4.9% |
| 560 | Syndactyly | 4.9% |
| 561 | Brachycephaly | 4.9% |
| 562 | Scimitar Syndrome | 4.8% |
| 563 | Parotid Neoplasms | 4.8% |
| 564 | Prostatic Neoplasms, Castration-Resistant | 4.8% |
| 565 | Nelson Syndrome | 4.8% |
| 566 | Congenital Hyperinsulinism | 4.7% |
| 567 | Chorioamnionitis | 4.7% |
| 568 | Tonsillar Neoplasms | 4.7% |
| 569 | Cerebellar Neoplasms | 4.6% |
| 570 | Laryngeal neoplasm | 4.6% |
| 571 | MELAS Syndrome | 4.5% |
| 572 | Amelia | 4.4% |
| 573 | Arachnodactyly | 4.4% |
| 574 | Ectopia Cordis | 4.4% |
| 575 | Ectromelia | 4.4% |
| 576 | Hemimelia | 4.4% |
| 577 | Meningomyelocele | 4.4% |
| 578 | Phocomelia | 4.4% |
| 579 | Sirenomelia | 4.4% |
| 580 | Spina Bifida | 4.4% |
| 581 | Polydactyly | 4.4% |
| 582 | Brachydactyly | 4.4% |
| 583 | Plagiocephaly | 4.4% |
| 584 | Lower Extremity Deformities, Congenital | 4.4% |
| 585 | Upper Extremity Deformities, Congenital | 4.4% |
| 586 | Single umbilical artery | 4.4% |
| 587 | Bladder Neoplasm | 4.4% |
| 588 | Kidney Neoplasm | 4.4% |
| 589 | Ureteral Neoplasms | 4.4% |
| 590 | Urethral Neoplasms | 4.4% |
| 591 | Blepharophimosis | 4.3% |
| 592 | Laryngostenosis | 4.3% |
| 593 | Mouth Abnormalities | 4.3% |
| 594 | Respiratory Distress Syndrome, Newborn | 4.3% |
| 595 | Poland Syndrome | 4.3% |
| 596 | Noonan Syndrome | 4.3% |
| 597 | Esophageal Atresia | 4.3% |
| 598 | Intestinal Atresia | 4.3% |
| 599 | Horseshoe Kidney | 4.3% |
| 600 | Pectus excavatum | 4.3% |
| 601 | Waldenstrom Macroglobulinemia | 4.3% |
| 602 | Multiple Myeloma | 4.3% |
| 603 | Klippel-Feil Syndrome | 4.3% |
| 604 | Gastroschisis | 4.3% |
| 605 | Synostosis | 4.3% |
| 606 | Acrodermatitis | 4.2% |
| 607 | Lymphangiectasis, Intestinal | 4.2% |
| 608 | Gianotti-Crosti Syndrome | 4.2% |
| 609 | Cleft Palate | 4.2% |
| 610 | Jaw Abnormalities | 4.1% |
| 611 | Cecal Neoplasms | 4.1% |
| 612 | Duodenal Neoplasms | 4.1% |
| 613 | Burkitt Lymphoma | 4.1% |
| 614 | Sezary Syndrome | 4% |
| 615 | Radicular Cyst | 4% |
| 616 | Abnormalities, Radiation-Induced | 4% |
| 617 | Appendiceal Neoplasms | 3.9% |
| 618 | Colonic Neoplasms | 3.9% |
| 619 | Rectal Neoplasms | 3.9% |
| 620 | Dermal Sinus | 3.9% |
| 621 | Spina Bifida Cystica | 3.9% |
| 622 | Spina Bifida Occulta | 3.9% |
| 623 | Lissencephaly | 3.9% |
| 624 | Polymicrogyria | 3.9% |
| 625 | Pachygyria | 3.9% |
| 626 | Schizencephaly | 3.9% |
| 627 | Periventricular Nodular Heterotopia | 3.9% |
| 628 | Zollinger-Ellison syndrome | 3.8% |
| 629 | Micrognathism | 3.7% |
| 630 | Pierre Robin Syndrome | 3.7% |
| 631 | Nasopharyngeal Neoplasms | 3.6% |
| 632 | Arthrogryposis | 3.6% |
| 633 | Choanal Atresia | 3.6% |
| 634 | Tracheobronchomegaly | 3.6% |
| 635 | Laryngocele | 3.6% |
| 636 | Hermaphroditism | 3.6% |
| 637 | Disorders of Sex Development | 3.6% |
| 638 | Colorectal Neoplasms | 3.6% |
| 639 | Cryptorchidism | 3.5% |
| 640 | Hypospadias | 3.5% |
| 641 | Aortic coarctation | 3.5% |
| 642 | Cor Triatriatum | 3.5% |
| 643 | Coronary Vessel Anomalies | 3.5% |
| 644 | Dental Enamel Hypoplasia | 3.5% |
| 645 | Patent ductus arteriosus | 3.5% |
| 646 | Ebstein Anomaly | 3.5% |
| 647 | Heart Septal Defects | 3.5% |
| 648 | Hyaline Membrane Disease | 3.5% |
| 649 | Hypodontia | 3.5% |
| 650 | Macrostomia | 3.5% |
| 651 | Meningocele | 3.5% |
| 652 | Microstomia | 3.5% |
| 653 | Tetralogy of Fallot | 3.5% |
| 654 | Transposition of Great Vessels | 3.5% |
| 655 | Hypoplastic Left Heart Syndrome | 3.5% |
| 656 | May-Thurner Syndrome | 3.5% |
| 657 | Encephalocele | 3.5% |
| 658 | Dandy-Walker Syndrome | 3.5% |
| 659 | Craniofacial Dysostosis | 3.5% |
| 660 | Leukomalacia, Periventricular | 3.4% |
| 661 | Wolff-Parkinson-White Syndrome | 3.4% |
| 662 | POEMS Syndrome | 3.4% |
| 663 | Nesidioblastosis | 3.4% |
| 664 | Ophthalmia Neonatorum | 3.4% |
| 665 | Anus Neoplasms | 3.4% |
| 666 | Sigmoid Neoplasms | 3.4% |
| 667 | Retrognathia | 3.3% |
| 668 | Paranasal Sinus Neoplasms | 3.2% |
| 669 | Aortopulmonary Septal Defect | 3.1% |
| 670 | Double Outlet Right Ventricle | 3.1% |
| 671 | Endocardial Cushion Defects | 3.1% |
| 672 | Myocardial bridging | 3.1% |
| 673 | Aorticopulmonary Septal Defect | 3.1% |
| 674 | Laryngomalacia | 3.1% |
| 675 | Maxillary Sinus Neoplasms | 3.1% |
| 676 | Pectus carinatum | 3% |
| 677 | Bladder Exstrophy | 3% |
| 678 | Epispadias | 3% |
| 679 | Hyperandrogenism | 3% |
| 680 | Multicystic Dysplastic Kidney | 3% |
| 681 | Prognathism | 2.9% |
| 682 | Truncus Arteriosus, Persistent | 2.9% |
| 683 | Goldenhar Syndrome | 2.9% |
| 684 | Long QT Syndrome | 2.9% |
| 685 | Platybasia | 2.9% |
| 686 | Tricuspid Atresia | 2.9% |
| 687 | Arrhythmogenic Right Ventricular Dysplasia | 2.9% |
| 688 | Gonadal Dysgenesis | 2.9% |
| 689 | Bronchomalacia | 2.9% |
| 690 | Adrenogenital Syndrome | 2.9% |
| 691 | Tracheomalacia | 2.9% |
| 692 | Ovotesticular Disorders of Sex Development | 2.9% |
| 693 | Kernicterus | 2.6% |
| 694 | Mandibulofacial Dysostosis | 2.6% |
| 695 | Romano-Ward Syndrome | 2.5% |
| 696 | Talipes | 2.4% |
| 697 | Congenital clubfoot | 2.3% |
| 698 | Vertical Talus | 2.3% |
| 699 | Arteriovenous fistula | 1.9% |